Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Common Cytokine Receptor γ Chain Family of Cytokines
Jian‐Xin Lin, Warren J. Leonard
Cold Spring Harbor Perspectives in Biology (2017) Vol. 10, Iss. 9, pp. a028449-a028449
Open Access | Times Cited: 154

Showing 26-50 of 154 citing articles:

Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis
Vivien Béziat
Human Genetics (2020) Vol. 139, Iss. 6-7, pp. 919-939
Open Access | Times Cited: 57
Cytokine engineering for targeted cancer immunotherapy
Lucia Bonati, Li Tang
Current Opinion in Chemical Biology (2021) Vol. 62, pp. 43-52
Open Access | Times Cited: 55
IL-2 Signaling Couples the MAPK and mTORC1 Axes to Promote T Cell Proliferation and Differentiation in Teleosts
Pengfei Mu, Jieying Huo, Xiaofeng Li, et al.
The Journal of Immunology (2022) Vol. 208, Iss. 7, pp. 1616-1631
Open Access | Times Cited: 37
Current Progress of CAR-NK Therapy in Cancer Treatment
Zhaojun Pang, Zhongyi Wang, Fengqi Li, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4318-4318
Open Access | Times Cited: 32
IL-22 as a target for therapeutic intervention: Current knowledge on its role in various diseases
Pranav Seth, Shweta Dubey
Cytokine (2023) Vol. 169, pp. 156293-156293
Closed Access | Times Cited: 18
Role of sex in immune response and epigenetic mechanisms
Sombodhi Bhattacharya, Debasmita Sadhukhan, Radha Saraswathy
Epigenetics & Chromatin (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model
Inés Sánchez-Moreno, Aritz Lasarte-Cía, Celia Martín-Otal, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e008572-e008572
Open Access | Times Cited: 6
Control of memory CD8+ T cell longevity and effector functions by IL-15
Jeffrey C. Nolz, Martin J. Richer
Molecular Immunology (2019) Vol. 117, pp. 180-188
Open Access | Times Cited: 51
Understanding SOCS protein specificity
Edmond M. Linossi, Dale J. Calleja, Sandra E. Nicholson
Growth Factors (2018) Vol. 36, Iss. 3-4, pp. 104-117
Closed Access | Times Cited: 47
Stem cell like memory T cells: A new paradigm in cancer immunotherapy
Fengdi Wang, Fanjun Cheng, Zheng Fang
Clinical Immunology (2022) Vol. 241, pp. 109078-109078
Open Access | Times Cited: 26
Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients
Jorge Monserrat, Ana M. Gómez-Lahoz, Miguel Á. Ortega, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10344-10344
Open Access | Times Cited: 25
Recent advances in JAK inhibitors for the treatment of metabolic syndrome
Debora Collotta, Maria Paola Franchina, V. Carlucci, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Cytokine Profile in Lung Cancer Patients: Anti-Tumor and Oncogenic Cytokines
Freddy Elad Essogmo, Angelina V. Zhilenkova, Yvan Sinclair Ngaha Tchawe, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5383-5383
Open Access | Times Cited: 14
JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma
Jihyun Kim, Jongho Ham, Hye‐Ryun Kang, et al.
Science Advances (2023) Vol. 9, Iss. 51
Open Access | Times Cited: 14
A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells
Peter J. Cook, Su Jung Yang, Gene I. Uenishi, et al.
Molecular Therapy (2023) Vol. 31, Iss. 8, pp. 2472-2488
Open Access | Times Cited: 13
Identification of a dual JAK3/TEC family kinase inhibitor for atopic dermatitis therapy
Y.C. Du, Longling Wang, Jingmei Zhou, et al.
Biochemical Pharmacology (2025) Vol. 232, pp. 116740-116740
Closed Access
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy
Kengo Tanigawa, William L. Redmond
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Survival expectations in melanoma patients: a molecular prognostic model associated with aging
Nenghua Zhang, Xinyi Qiu, Xiang Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Autophagy repression in effector T lymphocytes redefines paradigms in T cell biology
Ruchi Saxena, You‐Wen He
Nature Immunology (2025)
Closed Access
Foxp3+CD8+ regulatory T cells: bona fide Tregs with cytotoxic function
Shunqun Luo, Jemma H. Larson, Bruce R. Blazar, et al.
Trends in Immunology (2025)
Closed Access
Transcriptomic Dysregulation in Animal Models of Attention‐Deficit Hyperactivity Disorder and Nicotine Dependence Suggests Shared Neural Mechanisms
Sarah Van Horn, Heather Driscoll, Donna J. Toufexis
Brain and Behavior (2025) Vol. 15, Iss. 3
Open Access
STAT Signature Dish: Serving Immunity with a Side of Dietary Control
Hozaifa Metwally
Biomolecules (2025) Vol. 15, Iss. 4, pp. 487-487
Open Access
Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?
Przemysław Kotyla
BioMed Research International (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 42
Chromatin Accessibility and Interactions in the Transcriptional Regulation of T Cells
Peng Li, Warren J. Leonard
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 41
Evolution of developmental and comparative immunology in poultry: The regulators and the regulated
Mingmin Lu, Youngsub Lee, Hyun S. Lillehoj
Developmental & Comparative Immunology (2022) Vol. 138, pp. 104525-104525
Open Access | Times Cited: 19

Scroll to top